Pharmacological properties of angiotensin II receptor antagonists

Canadian Journal of Cardiology

Volumn 15, Issue SUPPL. F, 1999, Pages

  Timmermans, Pieter B M W M ^a  

^a AMGEN INC   (United States)

Author keywords

Angiotensin

Indexed keywords

ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; HYPERTENSION; METABOLISM; REVIEW;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION; MOLECULAR STRUCTURE; RECEPTORS, ANGIOTENSIN;

EID: 0033220662     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Duncia JV, Chiu AT, Carini DJ, et al. The discovery of potent nonpeptide angiotensin II receptor antagonists: A new class of potent antihypertensives. J Med Chem 1990;33:1312-29.
2. Wong PC, Price WA Jr, Chiu AT, et al. Nonpeptide angiotensin II receptor antagonists XI. Pharmacology of EXP3174: An active metabolite of DuP 753, and orally active antihypertensive agent. J Pharmacol Exp Ther 1990;255:211-7.
3. Wexler RR, Greenlee WJ, Irvin JD, et al. Nonpeptide angiotensin II receptor antagonists: The next generation in antihypertensive therapy. J Med Chem 1996;39:625-56.
4. Kenakin TP. The classification of drugs and drug receptors in isolated tissues. Pharmacol Rev 1984;36:165-222.
5. Timmermans PBMWM, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993;45:205-51.
6. Brunner HR. The new angiotensin II receptor antagonist, irbesartan. Pharmacokinetic and pharmacodynamic considerations. Hypertension 1997;10:311S-7S.
7. MacFadyen RJ, Reid JL. Angiotensin receptor antagonists as treatment for hypertension. J Hypertens 1994;12:1333-8.
8. Csajka C, Buclin T, Brunner HR, Biollaz J. Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists. Clin Pharmacokinet 1997;32:1-29.